- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2024 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Pharmaceutical Technology-06-02-2011
Pharmaceutical Technology
Statistics in the Service of Quality
June 02, 2011
Statistical Solutions
35
6
Ensuring compliance though increased statistical knowledge and resources.
The Pediatric Challenge
June 02, 2011
PharmTech Talk
35
6
Can microdosing make medicines safer and more effective for children?
Next-Gen Expression Systems
June 02, 2011
Special Report
35
6
More sophisticated biological expression systems expand the functionality of the traditional systems for protein synthesis.
A Comparison of Three Extrusion Systems (Part II)
June 02, 2011
Peer-Reviewed Research
35
6
The authors compare three systems of single-screw extrusion using binary formulations for their suitability for producing pellets of various formulations and under various spheronization conditions.
Following our Own Instructions
June 02, 2011
Insider Solutions
35
6
Why SOPs are rarely followed, often cited, and in need of follow-through.
21st Century Innovation
June 02, 2011
BioForum
35
6
Academic–industry partnerships are increasingly important in biopharmaceutical innovation.
In the Spotlight June 2011
June 02, 2011
In the Spotlight
35
6
Editor's picks of new manufacturing products for June 2011.
Global Healthcare on the Ground: BIO and BIO Ventures for Global Health
June 02, 2011
News
35
6
A Focus on Creative Strategies to Help the Developing World.
Wanted: Better Upstream Bioprocessing Technologies
June 02, 2011
Outsourcing Outlook
35
6
A recent industry survey shows keen interest in improving bioreactors and cell-culture media.
Inhibiting the Precipitation of Poorly Water-Soluble Drugs from Labrasol Formulations
June 02, 2011
Peer-Reviewed Research
35
6
The study results suggested that Pluronic F127 might be a potent inhibitor of drug precipitation for Labrasol formulations.
Safety Concerns and Shortages Challenge Pharma
June 02, 2011
Washington Report
35
6
Industry struggles to curb drug abuse, diversion, and disruptions in supply.
Quality Overload
June 02, 2011
Agent-in Place
35
6
Sometimes, there are just too many cooks in the kitchen.
Prevention of Microbial Contamination
June 02, 2011
Special Feature
35
6
A holistic approach to establishing robust control measures.
Advocating for Biosimilar Approval Standards Under BPCI
June 02, 2011
Viewpoint
35
6
FDA weighs multiple views regarding the Biologics Price Competition and Innovation Act.
The Means to Monitor Chemical Migration
June 02, 2011
Special Report
35
6
Industry associations will soon provide new recommendations about extractables and leachables.
Q&A with Christopher Meissner, Meissner
June 02, 2011
Industry Leader
35
6
Christopher Meissner, CEO of Meissner Filtration Products, on recent industry trends.
Policy and Leadership
June 02, 2011
Guest Editorial
35
6
This month's BIO Convention will encourage needed conversations.
Report from India
June 02, 2011
News
35
6
India's drug pricing authority increased the retail costs of certain domestically manufactured drugs, but not those of imported drug products. Pharma is asking why.
Optimizing High-Potency Manufacturing
June 02, 2011
Pharma Ingredients
35
6
Effective containment in API and drug-product manufacturing encompasses a variety of process, equipment, and operational issues.
Pharmaceutical Technology, June 2011 Issue (PDF)
June 01, 2011
Issue PDF
35
6
Next-Gen Expression Systems